Interview with Tido von Schoen-Angerer, Director, MSF Campaign for Access to Essential Medicines, on why trade regulations and intellectual property are so crucial in obtaining access to quality treatment in resource limited countries, and the case of compulsory licensing of drugs like Kaletra.
Link to this comment:
All Comments (0)